Approval in severe-to-profound and profound OTOF-related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of participants achieved or surpassed a hearing level meeting the ...

Approval in severe-to-profound and profound OTOF-related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of participants achieved or surpassed a hearing level meeting the ...

The FDA has granted accelerated approval to lunsotogene parvec-cwha (Otarmeni), an adeno-associated virus (AAV) vector–based ...

Dr. Purodha Prasad, ENT Specialist (Otolaryngologist) in Delhi & founder of Vanya Clinic, Aesthetics & ENT, recently treated ...

US health officials on Thursday greenlit a first-of-its-kind gene therapy to treat a rare form of hereditary hearing loss, a ...

A new study published in Otolaryngology–Head and Neck Surgery, the official peer-reviewed publication of the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF), finds that ...

Researchers say a gene therapy allowed deaf children and adults as old as 32 to hear for the first time. The benefits have ...

The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss ...

Miles McBride played again in Tuesday’s 111-94 loss to the Rockets and made it through 13 minutes unscathed, although his shooting rhythm clearly took a hit as he went 1-for-9 from the field. “It’s ...

I wonder where the story begins for this exploration of Croatian music. Maybe with my mother’s recollections of a holiday on Lošinj Island in Yugoslavia, in August 1985, seven months before I was born ...

Demand on the NSW surgical system is forcing one in 10 patients to wait more than a year for a 15-minute ear procedure, leaving children at risk of learning delays and long-term hearing loss. The ...